ABS TRACT Non-ketotic hyperglycaemic hemichorea is a rare syndrome characterized by a triad of hemichorea, hyperglycemia, and peculiar imaging abnormalities. Regression of symptoms is typically associated with normalisation of serum glucose levels and plasma osmolality. An 85 year-old female was admitted to the neurology clinic with left-sided involuntary movements. Magnetic resonance imaging of brain demonstrated hyperintensity on T1 weighted images. She was treated with clonazepam (12. 5 mg/ day) for symptomatic therapy. Hyperglycaemia was controlled using a combined therapy with insulin aspart and insülin glargine. The patient showed prompt improvement in her involuntary movements in a day. Acute or subacute onset of unilateral involuntary movements should suggest non-ketotic hyperglycaemic hemichorea, the recognition of which may result in prompt control of the symptoms by normalization of blood glucose.
Radiation myelopathy (RM) is a rare but serious complication of radiotherapy. Small vessel ischemia and demyelination are some of the more remarkable indications of RM's pathophysiology. The RM is a diagnosis of exclusion. In the differential diagnosis, infectious causes, tumors, rheumatic diseases, and paraneoplastic syndromes are the main diseases that should be excluded. Contrast-enhanced magnetic resonance imaging (MRI) is a useful method for diagnosis. We present a report on 3 patients diagnosed with radiation myelitis. All the patients presented with late paraparasia and paresthesia. Despite high-dose steroids, hyperbaric oxygen, and physical therapy, there was no clinical improvement at the follow-up one year later.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.